Study finds missed opportunities with COVID antivirals on Australian Pharmaceutical Benefits Scheme

Medicine Research News News

Study finds missed opportunities with COVID antivirals on Australian Pharmaceutical Benefits Scheme
Medicine ResearchHealth Research NewsHealth Research
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 45 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 51%

A new study has revealed significant discrepancies in the prescription of COVID-19 antivirals, indicating that many patients may not have received the most effective treatment available.

Study finds missed opportunities with COVID antivirals on Australian Pharmaceutical Benefits Scheme retrieved 11 July 2024 from https://medicalxpress.com/news/2024-07-opportunities-covid-antivirals-australian-pharmaceutical.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Think you've decided what to buy? Actually, your brain is still deciding—even as you put it in your basketUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

Medicine Research Health Research News Health Research Health Science Medicine Science

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study examines scale of US pharmaceutical industry sponsored eventsStudy examines scale of US pharmaceutical industry sponsored eventsPromotional events sponsored by the pharmaceutical industry that target health professionals responsible for prescribing medications, such as physicians and nurse practitioners, are a key component of promotional campaigns for new drugs and devices.
Read more »

New study highlights impact of sleep disturbances on COVID-19 and long COVIDNew study highlights impact of sleep disturbances on COVID-19 and long COVIDThe influence of pre-existing sleep disturbances on coronavirus disease 2019 (COVID-19) susceptibility, severity, and long-term effects.
Read more »

Workplace injury and illness costs tens of thousands of work years, Australian study findsWorkplace injury and illness costs tens of thousands of work years, Australian study findsAustralia loses 41,194 work years annually due to work-related injury, disease and mental health conditions, a new measure of the national burden of workplace injury and illness has found.
Read more »

Organized crime and domestic violence perps are big buyers of tracking devicesOrganized crime and domestic violence perps are big buyers of tracking devicesAustralian study finds GPS trackers – and sometimes AirTags – are in demand for the wrong reasons
Read more »

Study finds short-term side effects of COVID-19 mRNA vaccines boost long-term antibody responseStudy finds short-term side effects of COVID-19 mRNA vaccines boost long-term antibody responseShort-term adverse effects of COVID-19 mRNA vaccinations are linked to higher and longer-lasting neutralizing antibody responses, indicating robust immune efficacy.
Read more »

Study finds connection between cannabis use and increased risk of severe COVID-19Study finds connection between cannabis use and increased risk of severe COVID-19As the deadly disease that came to be known as COVID-19 started spreading in late 2019, scientists rushed to answer a critical question: Who is most at risk?
Read more »



Render Time: 2025-02-12 07:12:41